AMG 785 anti-sclerostin antibody: Phase Ib data

In a Phase Ib trial in healthy postmenopausal women, single doses of AMG 785 increased bone mineral density. AMGN has exclusive worldwide rights to develop and market therapeutics against sclerostin f...